Teprotumumab
From Infogalactic: the planetary knowledge core
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | IGF-1R |
| Identifiers | |
| CAS Number | 89957-37-9 |
| ATC code | none |
| UNII | Y64GQ0KC0A  |
| Chemical data | |
| Formula | C6476H10012N1748O2000S40 |
| Molecular mass | 145.6 kg/mol |
| (verify) | |
Teprotumumab is a human monoclonal antibody designed for the treatment of solid and hematologic tumors.
Teprotumumab was developed by Roche.
References
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Chemical articles having calculated molecular weight overwritten
- Drugs that are a monoclonal antibody
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Hoffmann-La Roche
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs
